SARS-CoV-2 vaccines induce a diverse spike-specific CD4+ T cell receptor repertoire in people living with HIV with low CD4 nadirs
Alicia Mercado, Joel Sop, Steven Amanat, Li Zhang, Natasha M. Chida, Christie R. Basseth, Kelly A. Gebo, Annukka A. R. Antar, Kellie N. Smith, Zhen Zeng, Joel N. Blankson

TL;DR
People with HIV and low CD4 counts can develop strong and diverse T cell responses to SARS-CoV-2 vaccines, with minimal influence from prior exposure to common cold coronaviruses.
Contribution
Demonstrates robust and diverse SARS-CoV-2-specific CD4+ T cell responses in HIV-positive individuals with low CD4 nadirs following vaccination.
Findings
Individuals with low CD4 counts showed strong T cell responses to SARS-CoV-2 spike protein.
Cross-reactive TCRs from common cold coronaviruses made up less than 10% of SARS-CoV-2-specific T cells.
SARS-CoV-2 T cell receptor diversity in HIV-positive individuals was comparable to that of healthy donors.
Abstract
People living with HIV with low CD4 T cell nadirs on antiretroviral therapy have suboptimal responses to immunization. We analyzed the SARS-CoV-2 spike-specific CD4+ T cell repertoire in individuals with CD4 nadirs of less than 100 cells/ul who received a primary SARS-CoV-2 mRNA vaccine series as well as the bivalent ancestral/BA.5 spike mRNA vaccine. We tested the hypothesis that antigenic imprinting would result in the preferential expansion of pre-existing cross-reactive T cells that were primed against the 4 common cold coronaviruses. We found that these individuals made robust effector and memory T cell responses to the SARS-CoV-2 spike protein that exceeded the responses to spike proteins from the common cold coronaviruses. Furthermore, in 4 individuals, the number of SARS-CoV-2 specific TCRs far exceeded the number of common cold coronavirus-specific T cell receptors. TCRs that…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies · Immune responses and vaccinations
